Invention Grant
- Patent Title: Genetic attenuation of plasmodium by B9 gene disruption
-
Application No.: US15458849Application Date: 2017-03-14
-
Publication No.: US09931389B2Publication Date: 2018-04-03
- Inventor: Chris J. Janse , Takeshi Annoura , Shahid M. Khan , Ben Van Schaijk , Ivo Hj Ploemen , Martijn W. Vos , Robert Sauerwein
- Applicant: SANARIA INC. , ACADEMISCH ZIEKENHUIS LEIDEN , STICHTING KATHOLIEKE UNIVERSTEIT
- Applicant Address: US MD Rockville NL Leiden NL Nijmegen
- Assignee: SANARIA INC.,ACADEMISCH ZIEKENHUIS LEIDEN,STICHTING KATHOLIEKE UNIVERSTEIT
- Current Assignee: SANARIA INC.,ACADEMISCH ZIEKENHUIS LEIDEN,STICHTING KATHOLIEKE UNIVERSTEIT
- Current Assignee Address: US MD Rockville NL Leiden NL Nijmegen
- Agency: Sterne, Kessler, Goldstein & Fox
- Agent Eldora Ellison; Bonnie Nannenga-Combs
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/015

Abstract:
Disclosed herein are mutant Plasmodium-species parasites that are genetically attenuated (GAP). They retain the ability to infect a host and invade host hepatocytes but subsequently their development is completely arrested within the liver stage of Plasmodium development and the parasites do not reach the blood stage of development. Vaccines and pharmaceutical compositions comprising genetically attenuated Plasmodium sporozoites as well as methods of using the same are likewise provided.
Public/Granted literature
- US20170252419A1 Genetic Attenuation of Plasmodium by B9 Gene Disruption Public/Granted day:2017-09-07
Information query